4//SEC Filing
Robichaud Albert 4
Accession 0001562180-21-006599
CIK 0001597553other
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 4:03 PM ET
Size
8.8 KB
Accession
0001562180-21-006599
Insider Transaction Report
Form 4
Robichaud Albert
Chief Scientific Officer
Transactions
- Award
Common Stock
2021-10-19+3,800→ 143,735 total - Tax Payment
Common Stock
2021-10-19$40.29/sh−1,116$44,964→ 142,619 total
Footnotes (2)
- [F1]On February 13, 2019, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 9,500 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on October 19, 2021, resulting in the vesting of the PSUs as to 3,800 shares.
- [F2]Reflects beneficial ownership balance which includes 284 shares purchased on June 30, 2021 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001612861
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 4:03 PM ET
- Size
- 8.8 KB